We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+14.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$19.8B
AUM Growth
+$2.97B
(+18%)
Cap. Flow
+$774M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
22.92%
Holding
1,110
New
158
Increased
343
Reduced
427
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$160M |
| 2 |
Old Dominion Freight Line
ODFL
|
+$113M |
| 3 |
Intel
INTC
|
+$107M |
| 4 |
Mastercard
MA
|
+$104M |
| 5 |
PayPal
PYPL
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$292M |
| 2 |
FedEx
FDX
|
+$188M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$173M |
| 4 |
Monster Beverage
MNST
|
+$135M |
| 5 |
Target
TGT
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.45% |
| 2 | Financials | 14.27% |
| 3 | Consumer Discretionary | 14.13% |
| 4 | Healthcare | 11.46% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
iRadimed
IRMD
$1.21B
| $614K | ﹤0.01% |
12,939
-128
| -1% | -$5.38K |
|
802
Microvast
MVST
$256M
| $607K | ﹤0.01% |
+433,694
| New | +$582K |
|
803
ESS Tech
GWH
$22.1M
| $605K | ﹤0.01% |
+35,366
| New | +$718K |
|
804
Phibro Animal Health
PAHC
$1.48B
| $592K | ﹤0.01% |
+51,083
| New | +$577K |
|
805
Inovio Pharmaceuticals
INO
$84.7M
| $586K | ﹤0.01% |
95,831
| – | – |
|
806
Quanex
NX
$893M
| $584K | ﹤0.01% |
19,103
-77,662
| -80% | -$2.29M |
|
|
GPMT
807
Granite Point Mortgage Trust
GPMT
$63.3M
| $578K | ﹤0.01% |
+97,279
| New | +$490K |
|
808
BioCryst Pharmaceuticals
BCRX
$2.48B
| $577K | ﹤0.01% |
96,397
-373,740
| -79% | -$2.17M |
|
809
eHealth
EHTH
$43.2M
| $567K | ﹤0.01% |
65,060
-33,820
| -34% | -$276K |
|
810
C4 Therapeutics
CCCC
$393M
| $567K | ﹤0.01% |
100,370
-764,111
| -88% | -$1.74M |
|
811
DexCom
DXCM
$28.9B
| $565K | ﹤0.01% |
4,551
-2,984
| -40% | -$305K |
|
|
PAMT
812
PAMT Corp
PAMT
$360M
| $564K | ﹤0.01% |
27,140
-3,918
| -13% | -$76.2K |
|
813
Prelude Therapeutics
PRLD
$370M
| $561K | ﹤0.01% |
131,307
-12,650
| -9% | -$38.5K |
|
814
Sierra Bancorp
BSRR
$536M
| $555K | ﹤0.01% |
24,592
-116
| -0.5% | -$2.25K |
|
815
Tango Therapeutics
TNGX
$4.34B
| $553K | ﹤0.01% |
55,814
-87,667
| -61% | -$761K |
|
|
SGMO
816
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $548K | ﹤0.01% |
1,008,062
+604,280
| +150% | +$279K |
|
817
Matador Resources
MTDR
$5.73B
| $547K | ﹤0.01% |
+9,626
| New | +$563K |
|
818
Southern Company
SO
$109B
| $544K | ﹤0.01% |
7,756
| – | – |
|
819
Healthpeak Properties
DOC
$15.7B
| $542K | ﹤0.01% |
27,380
-6,119
| -18% | -$108K |
|
820
CRA International
CRAI
$1.16B
| $536K | ﹤0.01% |
+5,426
| New | +$526K |
|
821
Heartland Express
HTLD
$1.04B
| $532K | ﹤0.01% |
+37,276
| New | +$510K |
|
|
TVRD
822
Tvardi Therapeutics
TVRD
$22.9M
| $518K | ﹤0.01% |
19,357
-20,757
| -52% | -$859K |
|
|
ONIT
823
Onity Group
ONIT
$341M
| $511K | ﹤0.01% |
16,615
-30,792
| -65% | -$788K |
|
824
Roblox
RBLX
$35.4B
| $508K | ﹤0.01% |
11,108
+390
| +4% | +$14.4K |
|
825
Hackett Group
HCKT
$266M
| $507K | ﹤0.01% |
22,271
+464
| +2% | +$10.5K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2023 Portfolio in Review
As of Q4 2023, Jacobs Levy Equity Management held 1,110 positions worth $19.8B, up 18% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management deployed $774M of net new capital in Q4 2023, opening 158 new positions and adding to 343 existing holdings. Its largest new stake was lululemon athletica: 370,681 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $292M trimmed.
- Jacobs Levy Equity Management's largest Q4 2023 buy was lululemon athletica: 370,681 shares worth $190M.
- Jacobs Levy Equity Management added most to Old Dominion Freight Line in Q4 2023, an estimated $113M increase.
- Jacobs Levy Equity Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $292M.
- Jacobs Levy Equity Management fully exited Okta in Q4 2023, selling an estimated $57.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $19.8B portfolio in Q4 2023.
- Jacobs Levy Equity Management opened 158 new positions and closed 147 in Q4 2023.
- Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $19.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.